Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32033 total
ASST has surged nearly 48% in five sessions, but the lending market tells a story of shorts still firmly in place — with a borrow pool that only just began to loosen after weeks of near-zero availability. The most…
USAR enters the back half of August with an uncomfortable split: short sellers are dug in at one of the highest levels in the mining sector, yet the lending market has quietly loosened this week — a tension worth…
Rezolve AI enters the final stretch before its September 1 earnings report with short sellers pulling back from extreme positions — yet the borrow market and options desk both suggest the underlying tension hasn't…
NIO enters its September 1 earnings release as one of the more shorted names in the EV universe, with positioning data pointing to bears who are dug in and not retreating. The short-side pressure is extreme by almost…
Red Cat Holdings heads into the final stretch of August with one of the more contradictory setups in small-cap defense: the lending pool is completely exhausted, yet short sellers have been steadily covering for a…
Arvinas heads into the back half of August with short sellers quietly retreating, options positioning turning more constructive, and the analyst community split between trimmed targets and stubborn buy ratings — all…
Beijing Changjiu Logistics heads into its August 24 earnings release carrying a modest one-month price recovery but a fragile technical foundation — and a history of selling off after results. The stock closed at CNY…
POET Technologies enters the week under pressure from multiple directions — the stock fell nearly 14% in five sessions while insiders sold at the top, and nearly one-in-five shares in the free float remains borrowed…
Seera Holding Group prints its August 24 results with board members sitting on paper gains from a multi-month buying campaign — the question now is whether the numbers validate that conviction. The insider buying…
Bill Gates filed a series of large purchases in RSG this week. The filings, reported between August 18–20, show Gates bought over 648,000 shares of Republic Services across six separate transactions. The combined value…
Zhejiang Supor enters its August 28 earnings release with insiders selling and the stock down 8% over the past month — a setup that puts the upcoming print under sharper focus than usual. The insider angle is the most…
XMA, the iShares S&P/TSX Capped Materials Index ETF, has become one of the stronger performers on the TSX this month — up nearly 29% over 30 days and 11.6% in the past week alone, closing at CAD 50.99. The price action…
Lucky Cement Limited enters the final stretch of August as a relative outlier in a sector that has broadly weakened — down just 1.4% on the week while most of its closest peers lost considerably more ground. The peer…
Alfresa Holdings heads into the final stretch of August with its lending market tightening meaningfully — borrow demand has roughly doubled since early July, even as the stock quietly extends a modest weekly gain. The…
ENRD has entered a new phase of bearish pressure this week — short interest has more than quadrupled since Monday while the lending market has tightened to its most extreme point in the recent record. The scale of the…
Infleqtion enters the post-earnings week with shorts in full retreat, calls still dominant, and the borrow market stubbornly locked — a setup that has visibly rewarded bulls over the past month. The clearest shift…
Beta Bionics heads into the back half of August with a striking contradiction at its core: short sellers are adding positions at their fastest rate in months, yet options traders are the most bullish they have been all…
Oruka Therapeutics heads into the back half of August with a striking split: short sellers have been quietly unwinding positions for a month while insiders cashed out in size last week. The most notable development…
Nuvectis Pharma enters the final week of August with a striking disconnect at its core: the stock has rallied 24% in a single week and is up more than 200% year-to-date, yet short interest remains elevated at nearly 7%…
Cytek Biosciences heads into the final stretch of August with short sellers quietly retreating, the borrow market extraordinarily relaxed, and the next earnings date already fixed for November — leaving the stock to…
